SCHEMBL845651

SCHEMBL845651

O=C(c1ccccc1)c1cccnc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ncccc3C(=O)c3ccccc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
TRPV1 Q8NER1 1/20 0.42
PABPC1 P11940 1/20 0.42
ALDH1A1 P00352 3/20 0.42
HTT P42858 2/20 0.42
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RHOC P08134 1/20 0.41
RHOA P61586 1/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
ROCK2 O75116 1/20 0.41
DGAT1 O75907 2/20 0.40
EP300 Q09472 1/20 0.40
CREBBP Q92793 1/20 0.40
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10119636 0.92 CYP2C9 (0.38) CYP2C9CYP2C19TRPV1PABPC1ALDH1A1
SCHEMBL13272509 0.85 TRPV1 (0.45) CYP2C9CYP2C19TRPV1PABPC1ALDH1A1
SCHEMBL845841 0.85 TRPV1 (0.45) CYP2C9CYP2C19TRPV1PABPC1ALDH1A1
SCHEMBL845704 0.85 TRPV1 (0.48) CYP2C9CYP2C19TRPV1PABPC1ALDH1A1
SCHEMBL845442 0.84 CYP2C9 (0.43) CYP2C9CYP2C19TRPV1PABPC1ALDH1A1
SCHEMBL845697 0.84 ALDH1A1 (0.45) CYP2C9CYP2C19PABPC1ALDH1A1HTT
SCHEMBL845300 0.83 CYP2C9 (0.54) CYP2C9CYP2C19PABPC1ALDH1A1HTT
SCHEMBL845708 0.82 RHOC (0.46) CYP2C9CYP2C19TRPV1PABPC1ALDH1A1
SCHEMBL844980 0.82 ALDH1A1 (0.45) CYP2C9CYP2C19TRPV1PABPC1ALDH1A1
SCHEMBL845060 0.81 KDM4E (0.51) CYP2C9CYP2C19PABPC1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed